A transcriptomics-based bioinformatics approach for identification and in vitro screening of fda-approved drugs for repurposing against dengue virus-2

HIGHLIGHTS

• who: Madhura Punekar and colleagues from the Pune, Maharashtra, India have published the research work: A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2, in the Journal: Viruses 2022, 14, x FOR PEER REVIEW of 15/06/2022
• what: The authors employed approach for drug identification Gene expression omnibus datasets from patients with different grades of disease severity and healthy controls were used to identify differentially expressed genes in cases which were then applied to the query tool of Connectivity Map to identify . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.